Insiders Ipsen S.A. OTC Markets

Equities

Market Closed - OTC Markets Other stock markets 19:41:09 17/07/2024 BST			5-day change	1st Jan Change
30.38 ^USD	-0.26%		+2.38%	+3.05%

07-11	CAC40: maintains gains after reassuring US inflation figures	CF
07-11	CAC40: rise without volume, W-Street at its zenith but falls back	CF

Ipsen Hires New Chief Corporate Affairs Officer	06-06	MT
Ipsen: new Chief Corporate Affairs Officer	06-06	CF
Ipsen Announces Executive Changes	05-02	CI
Ipsen: new President for North America	05-02	CF
Ipsen: appointment of an independent director	04/09/23	CF
Ipsen appoints new R&D Director	01/09/23	CF
Ipsen appoints new Medical Director	24/04/23	CF
France's Ipsen Names Chief Medical Officer	24/04/23	MT
Ipsen Appoints Sandra Silvestri as EVP, Chief Medical Officer and Head of Global Medical Affairs, Patient Safety and Patient Affairs, Effective 5 May 2023	24/04/23	CI
Lysogene: interim CFO confirmed	06/02/23	CF
Cann Group Appoints CEO	09/01/23	MT
OSE Immunotherapeutics Appoints Ipsen Executive As CEO	14/07/22	MT
Ipsen Appoints Catherine Abi-Habib as EVP Strategy, Transformation, and Digital	16/02/22	CI
Ipsen Nominates Karen Witts as New Independent Board Member	21/01/22	CI
Ipsen Appoints Stewart Campbell as Executive Vice President and President of North America	03/11/21	CI
Ipsen Appoints Mari Scheiffele as EVP and President, Specialty Care International, Effective November 1, 2021	11/10/21	CI
Mirati Therapeutics : taps industry veteran Meek as CEO	20/09/21	RE
Ipsen Appoints Gwenan White as Executive Vice President Communications and Public Affairs	21/01/21	CI
Ipsen Appoints Philippe Lopes-Fernandes as Executive Vice President, Chief Business Officer	25/09/20	CI
Ipsen Group Announces Executive Appointments	03/09/20	CI

No results for this search

IPSEN : Better-than-expected Q1; guidance unchanged

April 24, 2024 at 03:50 pm